beizray(Docetaxel)Medication DetailsZhuhai Beihai Biotech Co., Ltd.Usage: BEIZRAY, in combination with cisplatin and fluorouracil, is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).Medication DetailsDrug Interactions